You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Express Scripts
Merck
McKesson
Boehringer Ingelheim

Last Updated: July 11, 2020

DrugPatentWatch Database Preview

Patent: 8,623,354

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,623,354
Title:Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
Abstract: The present invention relates generally to treatment and prophylactic protocols for cellular diseases or disorders, such as diseases and disorders associated with abnormal cellular proliferation. More particularly, the present invention provides compositions comprising therapeutic antibodies and hyaluronan and their use in the treatment or prophylaxis of cellular diseases and disorders.
Inventor(s): Brown; Tracey J. (Flemington, AU), Brownlee; Gary R. (East Burwood, AU)
Assignee: Alchemia Oncology Pty Limited (Eight Mile Plains, AU)
Application Number:12/065,945
Patent Claims:see list of patent claims

Details for Patent 8,623,354

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 002 2017-06-22   Start Trial Alchemia Oncology Pty Limited (Eight Mile Plains, AU) 2025-09-07 RX Orphan search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 001 2017-06-22   Start Trial Alchemia Oncology Pty Limited (Eight Mile Plains, AU) 2025-09-07 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Start Trial Alchemia Oncology Pty Limited (Eight Mile Plains, AU) 2025-09-07 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Start Trial Alchemia Oncology Pty Limited (Eight Mile Plains, AU) 2025-09-07 RX Orphan search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18   Start Trial Alchemia Oncology Pty Limited (Eight Mile Plains, AU) 2025-09-07 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Colorcon
Johnson and Johnson
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.